We are live on ! Find out more
TNB

Thomasville National Bank Portfolio holdings

AUM $1.82B
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$547M
AUM Growth
+$44.2M
Cap. Flow
+$35.7M
Cap. Flow %
6.54%
Top 10 Hldgs %
28.45%
Holding
263
New
29
Increased
142
Reduced
52
Closed
13

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.9M
2
NVO
Novo Nordisk
NVO
+$2.63M
3
COR icon
Cencora
COR
+$2.62M
4
DGX icon
Quest Diagnostics
DGX
+$1.41M
5
RRC icon
Range Resources
RRC
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 16.09%
2 Healthcare 12.13%
3 Consumer Staples 10.51%
4 Industrials 9.83%
5 Technology 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLX icon
226
Deluxe
DLX
$1.19B
$223K 0.04%
3,220
OGE icon
227
OGE Energy
OGE
$9.66B
$222K 0.04%
6,376
-600
-9% -$21K
TXN icon
228
Texas Instruments
TXN
$258B
$221K 0.04%
2,879
+14
+0.5% +$1.12K
VOX icon
229
Vanguard Communication Services ETF
VOX
$5.74B
$218K 0.04%
2,377
+19
+0.8% +$1.8K
MDLZ icon
230
Mondelez International
MDLZ
$80.1B
$217K 0.04%
5,016
-618
-11% -$27.9K
NUE icon
231
Nucor
NUE
$61.5B
$216K 0.04%
+3,724
New +$218K
CCI icon
232
Crown Castle
CCI
$31.9B
$211K 0.04%
+2,102
New +$207K
KG
233
Kestrel Group
KG
$69.7M
$211K 0.04%
952
+252
+36% +$58.8K
VIG icon
234
Vanguard Dividend Appreciation ETF
VIG
$114B
$211K 0.04%
+2,279
New +$209K
LH icon
235
Labcorp
LH
$25.8B
$208K 0.04%
+1,571
New +$192K
EW icon
236
Edwards Lifesciences
EW
$51.6B
$204K 0.04%
+5,178
New +$189K
CIEN icon
237
Ciena
CIEN
$57.3B
$200K 0.04%
+8,000
New +$192K
NKE icon
238
Nike
NKE
$62.2B
$200K 0.04%
+3,396
New +$183K
NAD icon
239
Nuveen Quality Municipal Income Fund
NAD
$2.77B
$192K 0.04%
13,677
ET icon
240
Energy Transfer Partners
ET
$69.6B
$185K 0.03%
10,300
F icon
241
Ford
F
$55B
$155K 0.03%
13,861
+3,587
+35% +$40.1K
PSLV icon
242
Sprott Physical Silver Trust
PSLV
$13.3B
$84K 0.02%
+13,330
New +$87K
ABCB icon
243
Ameris Bancorp
ABCB
$5.9B
-9,160
Closed -$422K
COR icon
244
Cencora
COR
$61.9B
-29,598
Closed -$2.62M
ED icon
245
Consolidated Edison
ED
$39.5B
-2,828
Closed -$219K
NVO
246
Novo Nordisk
NVO
$207B
-153,336
Closed -$2.63M
ROST icon
247
Ross Stores
ROST
$81.3B
-3,372
Closed -$222K
RRC icon
248
Range Resources
RRC
$8.98B
-44,208
Closed -$1.29M
SJM icon
249
J.M. Smucker
SJM
$12.7B
-2,544
Closed -$333K
USB icon
250
US Bancorp
USB
$99.1B
-7,126
Closed -$367K

Similar funds

Thomasville National Bank's Q2 2017 Portfolio in Review

As of Q2 2017, Thomasville National Bank held 263 positions worth $547M, up 8.8% from $503M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Thomasville National Bank deployed $35.7M of net new capital in Q2 2017, opening 29 new positions and adding to 142 existing holdings. Its largest new stake was Celgene Corp: 37,525 shares worth $4.87M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.9M trimmed.

  • Thomasville National Bank's largest Q2 2017 buy was Celgene Corp: 37,525 shares worth $4.87M.
  • Thomasville National Bank added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $10.1M increase.
  • Thomasville National Bank's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $3.9M.
  • Thomasville National Bank fully exited Novo Nordisk in Q2 2017, selling an estimated $2.63M.
  • Thomasville National Bank's ten largest holdings make up 28% of its $547M portfolio in Q2 2017.
  • Thomasville National Bank opened 29 new positions and closed 13 in Q2 2017.
  • Thomasville National Bank's portfolio value rose 8.8% quarter-over-quarter to $547M.

Based on Thomasville National Bank's 13F filing for Q2 2017, filed 17 Jul 2017.